Algorithme Pharma Gains Key Patient Access Through Partnership with Hôpital Maisonneuve-Rosemont (HMR)

Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with Hôpital Maisonneuve-Rosemont (HMR).

(Laval, Québec, Canada December 11th, 2013) – Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with Hôpital Maisonneuve-Rosemont (HMR). The HMR clinical research team is comprised of over 60 clinicians and is supported by approximately 75 employees and as many graduate students and postgraduates. Together, they form an experienced network working in key therapeutic areas of research including Hematology, Oncology, Nephrology, Ophthalmology and Metabolic Diseases.

“As sponsors look to obtain more information on their lead drug earlier in development, the need to include patient populations in early stage clinical trials continues to increase. Partnering with research teams who have expertise in key therapeutic areas advances our goal of providing a full spectrum of Phase I/IIa clinical research services to our diverse client base” stated Dr. Marc Lefebvre, Vice-President Scientific & Regulatory Affairs, Algorithme Pharma Inc.

“In this partnership between private and academic organizations, our clinical investigators and researchers will be able to leverage Algorithme Pharma’s immense wealth of knowledge. For HMR and its Research Centre, this kind of collaboration is part of our strategic objectives which aim to continually deliver innovative treatments to our patients” said Dr. Pierre Dubé, Associate Director, Clinical Research Division, Hôpital Maisonneuve-Rosemont.

About Algorithme Pharma
Algorithme Pharma, an Altasciences Company, is a full service provider focused on early stage clinical research. With over 20 years’ experience, Algorithme Pharma successfully completes more than 200 clinical trials annually. Support services include large and small molecule Bioanalysis, Data Management, Biostatistics, Regulatory Support, Clinical Pharmacology and Project Management.

About Hôpital Maisonneuve-Rosemont (HMR)
Affiliated with Université de Montréal, Hôpital Maisonneuve-Rosemont (HMR) is a major institution where healthcare, teaching and medical research have converged since 1954. Its 5,500 employees and physicians, together with its 500 volunteers, work with the sizeable population of Montréal’s East-End and beyond, as the hospital also has a regional and extended regional mandate. HMR is home to a renowned research centre with four nationally and internationally recognized areas of expertise: Immuno-Oncology, Vision Health, Nephrology and Cellular Therapy.

Information:

Algorithme Pharma
Catherine Konidas
Vice-President Global Business Development
Tel.: 450-973-6077
ckonidas@algopharm.com | www.algopharm.com

Hôpital Maisonneuve-Rosemont (HMR)
Dr Pierre Dubé, M.D., M.Sc., F.R.C.S.
Associate Director – clinical research division
Tel : (514) 252-3400, ext. 4490
pierredube@videotron.qc.ca